News | June 16, 2014

Elsevier Acquires Amirsys

Amirsys’ point-of-care decision support technology to augment Elsevier’s evidence-based clinical solutions suite

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today the acquisition of Amirsys.

Focused on visually oriented medical disciplines like radiology, pathology and anatomy, Amirsys’ global solutions give healthcare providers the expert information and clinical decision support (CDS) tools to make informed, expert and evidence-based diagnoses. Amirsys also provides learning environments that help those training in these disciplines to sharpen their diagnostic skills and increase their knowledge.

“This acquisition bolsters Elsevier’s comprehensive set of point-of-decision solutions, providing our customers around the world with a greater ability to improve the quality of care and patient outcomes,” said Jay Katzen, president, Elsevier Clinical Solutions. “In addition, because radiology, pathology, anatomy and their associated content and data-rich images are foundational elements of other disciplines, we believe Amirsys will improve our ability to better inform diagnostic and treatment decisions across a broad scope of other specialties.”

Amirsys also created sophisticated technology tools to develop and maintain current imaging content, and Elsevier expects to be able to adapt those tools to serve other visually rich specialties. Amirsys products include STATdx, RADPrimer, ImmunoQuery, AnatomyOne and Amirsys imaging, pathology and anatomy reference centers. Amirsys will be integrated with the Elsevier Clinical Solutions suite, which includes clinical workflow and decision support, clinical reference and patient engagement, including ClinicalKey, CPM CarePoints, ExitCare, and InOrder by Elsevier.

“Elsevier is known for our trusted, evidence-based content, and the Amirsys team, products and solutions add substantial global expertise and technology to our suite of solutions,” Katzen said. “The Amirsys content development and technology platform enhances our ability to frequently update and manage images and text assets throughout our clinical solutions suite so that our customers always have access to the most current content available.”

Amirsys will continue its tradition of publishing new radiology and pathology reference texts with Elsevier. Amirsys’ new editions and titles, publishing group and world-renowned author teams will complement Elsevier’s own portfolio of high quality radiology and pathology titles.

“We are excited to become part of Elsevier’s premier suite of clinical solutions,” said Paul Scholtes, co-CEO of Amirsys. “Together we address the needs of radiology and diagnostic pathology professionals, hospitals, and physicians’ practices whose clinicians must have the best information and technology in order to deliver a quality diagnosis,” said Ric Harnsberger, M.D., co-CEO of Amirsys.

Amirsys is headquartered in Salt Lake City, Utah. The acquisition is effective immediately and financial terms of the transaction are not being disclosed.

For more information:

Related Content

Siemens Healthineers Launches New Partners for Digital Ecosystem at HIMSS 2018
News | PACS Accessories | March 12, 2018
At the 2018 Healthcare Information and Management Systems Society (HIMSS) Annual Conference and Exhibition, March 5-9...
Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer
News | PET Imaging | February 21, 2018
Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive...
FDA Clears First AI-Powered Clinical Decision Support Software for Stroke
Technology | Clinical Decision Support | February 14, 2018
The U.S. Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact application, the first ...
Elekta and IBM Watson Health Bringing Artificial Intelligence to Oncology
News | Oncology Diagnostics | January 31, 2018
Elekta announced it is collaborating with IBM Watson Health to offer Watson for Oncology with Elekta’s cancer care...
MedCurrent Rolls Out OrderWise Clinical Decision Support Platform With iRefer Guidelines
Technology | Clinical Decision Support | January 29, 2018
Primary care providers and hospital doctors around the world can now access the imaging referral guidelines from the U....
National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC).

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC). 

Feature | Clinical Decision Support | January 18, 2018
January 18, 2018 — Change Healthcare announced the acquisition of National Decision Support Company (NDSC), a leader
News | Clinical Decision Support | January 12, 2018
January 12, 2018 — GE Healthcare has entered into a strategic, long-term partnership with Roche to jointly develop an
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Mirada Medical and Optellum Debut AI-Based Lung Cancer Diagnosis Solution at RSNA 2017
News | Computed Tomography (CT) | December 14, 2017
Optellum, a high-tech startup in lung cancer and machine learning, and Mirada Medical recently announced a partnership...
HealthMyne Highlights Value of Quantitative Data in Oncology Reads at RSNA 2017
News | Clinical Decision Support | November 17, 2017
November 17, 2017 — At the 2017 Radiological Society of North America (RSNA) conference, HealthMyne will demonstrate
Overlay Init